Senate Bill
S. 475
Alternatives to PAIN Act
Primary Sponsor

Martin Heinrich
Senator
Cosponsors
30
Quick Stats
Policy Area
Summary
This bill improves Medicare coverage for non-opioid pain management drugs by eliminating deductibles, placing them on the lowest cost-sharing tier, and prohibiting prior authorization and step therapy requirements that could delay access to these alternatives.
Latest Action
Read twice and referred to the Committee on Finance.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Alternatives to PAIN Act
This bill improves Medicare coverage for non-opioid pain management drugs by eliminating deductibles, placing them on the lowest cost-sharing tier, and prohibiting prior authorization and step therapy requirements that could delay access to these alternatives.
Community Breakdown
Pass
0%
Fail
0%
0 predictions
This bill improves Medicare coverage for non-opioid pain management drugs by eliminating deductibles, placing them on the lowest cost-sharing tier, and prohibiting prior authorization and step therapy requirements that could delay access to these alternatives.
- Bill Number
- 475
- Sponsor
- Martin Heinrich (D-NM)
- Introduced
- 2/6/2025
- Status
- Read twice and referred to the Committee on Finance.
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- Alternatives to PAIN Act
- Bill Number
- 475
- Sponsor
- Martin Heinrich (D-NM)
- Status
- Read twice and referred to the Committee on Finance.
- Introduced
- 2/6/2025
- Summary
- This bill improves Medicare coverage for non-opioid pain management drugs by eliminating deductibles, placing them on the lowest cost-sharing tier, and prohibiting prior authorization and step therapy requirements that could delay access to these alternatives.
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.